Next-Generation DPP1 Inhibitor therapy(Insmed)

N/A

Report date: 2024/11/21 17:06:03
NME

Base Information

Drug NameNext-Generation DPP1 Inhibitor therapy(Insmed)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInsmed Inc
China Registration ClassN/A

Develop Information

Active CompaniesInsmed Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A